The level of indoleamine 2, 3-dioxygenase 1, which is a rate-limiting enzyme that converts tryptophan to kynurenine, is upregulated in multiple types of cancer, suggesting a possible role in carcinogenesis and as a potential biomarker [35]. This evidence concerns the gene IDO1 and cancer.